Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shancol Dosing Interval Immunogenicity
NCT01233362Phase 2Completed
- Sponsor
- International Vaccine Institute
- Start
- Dec 2010
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Killed bivalent (O1 and O139) whole cell oral cholera vaccine in cholera, sponsored by International Vaccine Institute. Started Dec 2010; status: completed.
02
Drugs
Killed bivalent (O1 and O139) whole cell oral cholera vaccine
03
Conditions
cholera
Beyond the preview
Go deeper on NCT01233362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233362.